Literature DB >> 7193686

Predictors of the outcome of transsphenoidal surgery for prolactin-secreting pituitary adenomas.

J Schlechte, J Vangilder, B Sherman.   

Abstract

Sixty-seven women who underwent transsphenoidal resection of PRL-secreting pituitary adenomas between 1976 and 1979 were separated into categories according to the manner of their clinical presentation. Forty-one had oral contraceptive-related onset of amenorrhea-galactorrhea, 5 had pregnancy-related onset of amenorrhea-galactorrhea, 5 had primary amenorrhea, and 16 had the spontaneous onset of amenorrhea-galactorrhea unrelated to estrogen use. Surgical success, defined as the resumption of regular menses and normalization of serum PRL concentration, was achieved in 54% of those with estrogen-related onset of amenorrhea-galactorrhea compared with 19% in the other group. The analysis of multiple preoperative features, including clinical classification, age, preoperative PRL concentration, and duration of amenorrhea-galactorrhea by logistic regression, demonstrated that the clinical classification was the most important factor in predicting the outcome of transsphenoidal surgery. It should be a prime consideration in the selection of therapy for PRL-secreting adenomas.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7193686     DOI: 10.1210/jcem-52-4-785

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  4 in total

Review 1.  New insights in prolactin: pathological implications.

Authors:  Valérie Bernard; Jacques Young; Philippe Chanson; Nadine Binart
Journal:  Nat Rev Endocrinol       Date:  2015-03-17       Impact factor: 43.330

2.  Enlarged adenomectomy for enclosed prolactinomas: a preliminary study of 26 cases.

Authors:  F Grisoli; T Brue; N Graziani; R Costa; J Trouillas; D Begou; P Jaquet
Journal:  Acta Neurochir (Wien)       Date:  1990       Impact factor: 2.216

3.  Extra-Pseudocapsular Transsphenoidal Surgery for Microprolactinoma in Women.

Authors:  Juan Chen; Xiang Guo; Zhuangzhuang Miao; Zhuo Zhang; Shengwen Liu; Xueyan Wan; Kai Shu; Yan Yang; Ting Lei
Journal:  J Clin Med       Date:  2022-07-05       Impact factor: 4.964

4.  Estrogenic treatment does not modify the TSH and PRL responses to domperidone and TRH in patients with tumoral hyperprolactinemia.

Authors:  E Ghigo; G Pogliano; C Campagnoli; A Bertagna; F Camanni; F Massara
Journal:  J Endocrinol Invest       Date:  1984-10       Impact factor: 4.256

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.